Neurotechnologies to Understand and Repair Nervous Systems via Targeted Gene Therapy

The Gradinaru Lab develops custom recombinant adeno-associated viruses (AAVs) for more efficient and targeted gene transfer in vivo and uses advanced technologies such as optogenetics, CLARITY, physiology, imaging, and behavior to understand and develop therapies for neurological diseases

Research Highlights

Research

Publications

Talks by Dr. Gradinaru

News

Awards

People

Life @GLab/Caltech

Resources